Related Experiment Video
Updated: Jul 14, 2026

Visualization of HIV-1 Gag Binding to Giant Unilamellar Vesicle (GUV) Membranes
Published on: July 28, 2016
Mutations in capsid major homology region affect assembly and membrane affinity of HIV-1 Gag
Yu-Fen Chang1, Shiu-Mei Wang, Kuo-Jung Huang
1Institute of Public Health, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Abstract:
We introduced mutations into the HIV-1 major homology region (MHR; capsids 153-172) and adjacent C-terminal region to analyze their effects on virus-like particle (VLP) assembly, membrane affinity, and the multimerization of the Gag structural protein. Results indicate that alanine substitutions at K158, F168 or E175 significantly diminished VLP production. All assembly-defective Gag mutants had markedly reduced membrane-binding capacities, but results from a velocity sedimentation analysis suggest that most of the membrane-bound Gag proteins were present, primarily in a higher-order multimerized form. The membrane-binding capacity of the K158A, F168A, and E175A Gag proteins increased sharply upon removal of the MA globular domain. While demonstrating improved multimerization capability, the two MA-deleted versions of F168A and E175A did not show marked improvement in VLP production, presumably due to a defect in association with the raft-like membrane domain. However, K158A bound to detergent-resistant raft-like membrane; this was accompanied by noticeably improved VLP production following MA removal. Our results suggest that the HIV-1 MHR and adjacent downstream region facilitate multimerization and tight Gag packing. Enhanced Gag multimerization may help expose the membrane-binding domain and thus improve Gag membrane binding, thereby promoting Gag multimerization into higher-order assembly products.
Insights
Mutations in HIV-1
Area of Science:
- Virology
- Structural Biology
- Molecular Biology
Background:
- The human immunodeficiency virus type 1 (HIV-1) Gag polyprotein is essential for viral assembly.
- Gag multimerization and membrane binding are critical steps in the HIV-1 replication cycle.
Purpose of the Study:
- To investigate the role of the major homology region (MHR) and adjacent C-terminal regions in HIV-1 Gag assembly.
- To analyze the impact of specific mutations on Gag multimerization, membrane binding, and virus-like particle (VLP) production.
Main Methods:
- Site-directed mutagenesis to introduce alanine substitutions at key residues (K158, F168, E175) within the HIV-1 MHR and C-terminal regions.
- Analysis of VLP assembly and production.
- Assessment of Gag membrane-binding capacity using velocity sedimentation and detergent-resistant membrane assays.
- Evaluation of Gag multimerization and the effect of MA domain removal.
Main Results:
- Mutations at K158, F168, and E175 significantly impaired VLP production and Gag membrane binding.
- Assembly-defective mutants showed increased Gag multimerization, particularly upon removal of the MA domain.
- K158A mutant demonstrated enhanced VLP production after MA removal, binding to detergent-resistant membranes.
- F168A and E175A mutants, despite improved multimerization, failed to significantly increase VLP production without MA, suggesting defects in raft-like membrane association.
Conclusions:
- The HIV-1 MHR and adjacent downstream regions are crucial for Gag multimerization and tight packing during VLP assembly.
- Enhanced Gag multimerization promotes Gag membrane binding and facilitates efficient VLP formation.
- Specific interactions with raft-like membrane domains are essential for optimal Gag assembly and VLP production.
More Related Videos
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Viral Structure
Leaky Scanning
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Inhibitors Of Virion Release

